Ken Griffin X Biotech Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in X Biotech Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,300 shares of XBIT stock, worth $32,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,300
Previous 800
687.5%
Holding current value
$32,381
Previous $3,000
1600.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XBIT
# of Institutions
47Shares Held
3.96MCall Options Held
6.3KPut Options Held
1.7K-
Israel Englander Millennium Management LLC | New York, Ny927KShares$4.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA895KShares$4.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY307KShares$1.58 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$1.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA195KShares$1 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $156M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...